Page last updated: 2024-08-25

squalamine and Macular Edema

squalamine has been researched along with Macular Edema in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hu, AY; Wroblewski, JJ	1

Trials

1 trial(s) available for squalamine and Macular Edema

Article	Year
Topical Squalamine 0.2% and Intravitreal Ranibizumab 0.5 mg as Combination Therapy for Macular Edema Due to Branch and Central Retinal Vein Occlusion: An Open-Label, Randomized Study. Ophthalmic surgery, lasers & imaging retina, 2016, Oct-01, Volume: 47, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Cholestanols; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ranibizumab; Retinal Vein Occlusion; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity	2016

Article

Year

Topical Squalamine 0.2% and Intravitreal Ranibizumab 0.5 mg as Combination Therapy for Macular Edema Due to Branch and Central Retinal Vein Occlusion: An Open-Label, Randomized Study.

Ophthalmic surgery, lasers & imaging retina, 2016, Oct-01, Volume: 47, Issue:10

Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Cholestanols; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ranibizumab; Retinal Vein Occlusion; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity

2016